Blueray Med Secures Tens of Millions in Series A+ Financing for Advanced Laser Medicine Devices
Blueray Med, a leading high-end laser medicine device manufacturer based in Xi’an, has reportedly secured...
Specialised Therapeutics to Commercialize Akeso’s PD-1 Inhibitor Penpulimab in APAC
Singapore-based Specialised Therapeutics Asia Pte Ltd (ST) has been appointed to handle the commercialization of...
Legend Biotech Appoints Dr. Mythili Koneru as Chief Medical Officer to Lead Clinical Development
China-based Legend Biotech Corporation (NASDAQ: LEGN) has announced the appointment of Dr. Mythili Koneru as...
Luye Pharma’s Bevacizumab Biosimilar Accepted for Review in Brazil by ANVISA
China-based Luye Pharma Group (HKG: 2186) has announced that the market approval filing for its...
Round 8 VBP Tender Results: RMB 3.775 Billion Awarded Across 152 Manufacturers
The official results of Round 8 of China’s national Volume-Based Procurement (VBP) tender program have...
Priority Review Status Anticipated for HH-003, BI655130, VIS649, and Remternetug by CDE
The Center for Drug Evaluation (CDE) website has indicated that Huahui Health’s HH-003, Boehringer Ingelheim’s...
Bristol-Myers Squibb Launches Zeposia in China for Multiple Sclerosis Treatment
Global pharmaceutical company Bristol-Myers Squibb (BMS, NYSE: BMY) has announced the market launch in China...
Hubei Implements Inter-Provincial VBP Tender Results for Pacemakers
The Hubei provincial Drug and Instrument Procurement Platform has issued a notice regarding the implementation...
Zelgen Biopharmaceuticals’ ZG006 Earns FDA Approval for Small-Cell Lung Cancer Trial
China-based Suzhou Zelgen Biopharmaceuticals Co., Ltd (SHA: 688266) has announced receiving clinical trial approval from...
JW Therapeutics’ Carteyva Receives NMPA Approval for Moderate-to-Severe SLE Clinical Trial
China-based JW Therapeutics (HKG: 2126) has announced receiving tacit clinical trial approval from the National...
Hua Medicine Partners with 111 Inc. for Dorzagliatin Sales and Distribution in China
China-based Hua Medicine (HKG: 2552) has announced a sales and distribution agreement with online pharma...
CStone Pharmaceuticals Reduces Ayvakit Price to Boost Accessibility in China
China-based CStone Pharmaceuticals (HKG: 2616) has announced a lower recommended price for its precision medicine...
Hangzhou Baikai Biomedical and Leads Biolabs Partner to Develop Innovative ADCs
China-based Hangzhou Baikai Biomedical Co., Ltd and Leads Biolabs Inc. have announced a partnership aimed...
NHC Report: Performance Assessment of National Class 2 Public Hospitals in 2021
The National Health Commission (NHC) has released the “Report on the National Monitoring and Analysis...
Cuban-Chinese Biotechnology Center Showcases Drug and Vaccine Progress to Cuban Delegation
Researchers from Cuba and China at the Yongzhou joint biotechnology innovation center in China’s Hunan...
Hebei Leads Sanming Alliance in Launching 8th VBP for 19 Medical Consumables
The Hebei medical drug and device centralized procurement center has announced the start of the...
Takeda Pharma’s Iclusig Poised for Priority Review by CDE for Leukemia Treatments
The Center for Drug Evaluation (CDE) website has indicated that Takeda Pharma’s (TYO: 4502) Iclusig...
Arctic Vision Partners with Sinopharm Group for Ophthalmic Product Distribution in China
China-based ophthalmology specialist Arctic Vision has entered into a strategic partnership with Sinopharm Group Distribution...
FDA Issues Complete Response Letters to Six Novel Drugs in Q1 2023
According to an analysis, the US FDA issued complete response letters (CRLs) to six novel...
Bioyond Robotics Secures $29 Million in Series A and A+ Financing Rounds
Bioyond Robotics, a Shanghai-based intelligent automation company, has reportedly raised around RMB 200 million (USD...